Purchase Order 75N93023P00581
Award Date 7/1/23
Potential Completion Date 6/30/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $58,588.77 contract is for the procurement of a QIACUBE (110V) laboratory instrument, part number 9001292. This award supports NIAID's biomedical research, public health, and healthcare programs. Qiagen is an established federal contractor, providing a range of molecular...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the QIAGILITY equipment and related services. The potential value of this contract is $3,821.40, with a period of performance ending on July 27, 2018. Qiagen is a global provider of sample and assay technologies that supports federal agencies' biomedical research, public health, law...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for an annual service agreement for nucleic acid extraction equipment, valued at $10,410.00, with an award date of May 15, 2020 and completion date of May 14, 2021. Work is performed in Germantown, Maryland. The order is priced on a firm fixed price basis with no set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,348.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The service agreement, which does not have a set-aside designation, is for Qiagen's QIAGILLITY products and services. Qiagen is an experienced federal contractor, having provided a range of molecular diagnostics, biotechnology, and bioinformatics...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC for $28,440.75. The contract is for the QIAGEN QIAcube HT/QIAxtractor System, which are sample and assay technologies used to support federal agencies' biomedical research, public health, and healthcare programs. Qiagen, LLC is a subsidiary of the multinational biotechnology company...
- This is a $14,088 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of specialized scientific equipment and reagents. The contract is for the supply of QIACUBE HT instruments and related equipment and services. Qiagen is an experienced federal contractor, holding several indefinite delivery vehicles (IDVs) with agencies like the FBI and Department of Veterans...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for a full service agreement on QIAXTRACTOR/QIACUBE HT systems. The contract has a ceiling value of $10,698.00 and a period of performance through April 30, 2022. Qiagen, LLC is a division of the parent company Qiagen N.V., which is an international provider of sample and assay technologies...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $13,166 to Qiagen, LLC of Germantown, Maryland. The one-year contract provides full agreement service for two QIACUBE HT/QIAXTRACTOR platforms from July 1, 2023 to June 30, 2024. Qiagen, LLC is a subsidiary of Qiagen N.V. and will perform the entirety of the contract within the United States. The award is likely in support of the National Institute of Allergy and Infectious Diseases' research into allergies and infectious diseases through provision of service and maintenance for automated nucleic acid extraction platforms.
Generated 12/20/23, 4:43 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 5/8/23 |